(VIANEWS) – Netlist (NLST), Opiant Pharmaceuticals (OPNT), Falcon Minerals Corporation (FLMN) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Netlist (NLST)

122.2% sales growth and 48.3% return on equity

Netlist, Inc. designs, manufactures, and sells modular memory subsystems for the server, high-performance computing, and communications markets worldwide.

Netlist’s sales growth this year is anticipated to be 183.7% and a negative 6.7% for next year.

Year-on-year quarterly revenue growth grew by 161.9%, now sitting on 117.49M for the twelve trailing months.

Volume

Today’s last reported volume for Netlist is 395078 which is 51.09% below its average volume of 807791.

Netlist’s sales growth for the next quarter is 122.2%. The company’s growth estimates for the present quarter and the next is a negative 400% and negative -100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.3%.

Volatility

Netlist’s last day, last week, and last month’s current intraday variation average was 1.55%, 3.60%, and 7.00%, respectively.

Netlist’s highest amplitude of average volatility was 10.89% (day), 10.96% (last week), and 12.02% (last month), respectively.

Netlist’s Stock Yearly Top and Bottom Value

Netlist’s stock is valued at $4.60 at 19:22 EST, way below its 52-week high of $10.20 and way above its 52-week low of $0.89.

Netlist’s Moving Average

Netlist’s value is way under its 50-day moving average of $5.58 and way under its 200-day moving average of $5.42.

2. Opiant Pharmaceuticals (OPNT)

56.6% sales growth and 4.05% return on equity

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.

Opiant Pharmaceuticals’s sales growth this year is expected to be 59.4% and a negative 41.3% for next year.

Year-on-year quarterly revenue growth grew by 79.4%, now sitting on 43.91M for the twelve trailing months.

Volume

Today’s last reported volume for Opiant Pharmaceuticals is 62489 which is 12.07% below its average volume of 71073.

Opiant Pharmaceuticals’s sales growth for the next quarter is 56.6%. The company’s growth estimates for the ongoing quarter and the next is 93.8% and 69.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.05%.

Volatility

Opiant Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 1.69%, 4.01%, and 3.70%, respectively.

Opiant Pharmaceuticals’s highest amplitude of average volatility was 5.80% (day), 7.40% (last week), and 8.50% (last month), respectively.

Opiant Pharmaceuticals’s Stock Yearly Top and Bottom Value

Opiant Pharmaceuticals’s stock is valued at $30.84 at 19:22 EST, way under its 52-week high of $37.71 and way higher than its 52-week low of $10.00.

Opiant Pharmaceuticals’s Moving Average

Opiant Pharmaceuticals’s value is above its 50-day moving average of $29.98 and way above its 200-day moving average of $21.79.

3. Falcon Minerals Corporation (FLMN)

45.2% sales growth and 7.64% return on equity

Falcon Minerals Corporation acquires and owns mineral, royalty, and over-riding royalty interests in oil and natural gas properties in North America.

Falcon Minerals Corporation’s sales growth this year is anticipated to be 68.9% and 19.7% for next year.

Year-on-year quarterly revenue growth grew by 103.6%, now sitting on 63.62M for the twelve trailing months.

Volume

Today’s last reported volume for Falcon Minerals Corporation is 438914 which is 41.82% below its average volume of 754509.

Falcon Minerals Corporation’s sales growth for the next quarter is 45.2%. The company’s growth estimates for the ongoing quarter and the next is 600% and 366.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.64%.

Volatility

Falcon Minerals Corporation’s last day, last week, and last month’s current intraday variation average was 2.37%, 3.64%, and 1.98%, respectively.

Falcon Minerals Corporation’s highest amplitude of average volatility was 3.83% (day), 7.10% (last week), and 4.85% (last month), respectively.

Falcon Minerals Corporation’s Stock Yearly Top and Bottom Value

Falcon Minerals Corporation’s stock is valued at $5.61 at 19:22 EST, way under its 52-week high of $6.58 and way above its 52-week low of $3.88.

Falcon Minerals Corporation’s Moving Average

Falcon Minerals Corporation’s value is way above its 50-day moving average of $5.01 and way above its 200-day moving average of $5.02.

4. Cutera (CUTR)

40.4% sales growth and 15.25% return on equity

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide.

Cutera’s sales growth this year is anticipated to be 53.5% and 8.9% for next year.

Year-on-year quarterly revenue growth grew by 46.6%, now sitting on 215.58M for the twelve trailing months.

Volume

Today’s last reported volume for Cutera is 152586 which is 9.75% below its average volume of 169077.

Cutera’s sales growth for the next quarter is 40.4%. The company’s growth estimates for the current quarter and the next is a negative 54.8% and negative -29.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.25%.

Volatility

Cutera’s last day, last week, and last month’s current intraday variation average was 0.05%, 2.42%, and 2.50%, respectively.

Cutera’s highest amplitude of average volatility was 3.94% (day), 4.65% (last week), and 5.62% (last month), respectively.

Cutera’s Stock Yearly Top and Bottom Value

Cutera’s stock is valued at $37.79 at 19:22 EST, way below its 52-week high of $60.36 and way higher than its 52-week low of $25.01.

Cutera’s Moving Average

Cutera’s worth is higher than its 50-day moving average of $36.70 and way under its 200-day moving average of $42.63.

5. First Guaranty Bancshares (FGBI)

17% sales growth and 13.56% return on equity

First Guaranty Bancshares, Inc. operates as the holding company for First Guaranty Bank that provides commercial banking services in Louisiana and Texas.

First Guaranty Bancshares’s sales growth this year is expected to be 14.5% and 8.5% for next year.

Year-on-year quarterly revenue growth grew by 18.1%, now sitting on 98.32M for the twelve trailing months.

Volume

Today’s last reported volume for First Guaranty Bancshares is 766 which is 92.58% below its average volume of 10334.

First Guaranty Bancshares’s sales growth for the next quarter is 17%. The company’s growth estimates for the present quarter and the next is 25.5% and 3.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.56%.

Volatility

First Guaranty Bancshares’s last day, last week, and last month’s current intraday variation average was 0.96%, 1.81%, and 1.23%, respectively.

First Guaranty Bancshares’s highest amplitude of average volatility was 3.06% (day), 3.10% (last week), and 2.85% (last month), respectively.

First Guaranty Bancshares’s Stock Yearly Top and Bottom Value

First Guaranty Bancshares’s stock is valued at $20.92 at 19:22 EST, under its 52-week high of $23.06 and way above its 52-week low of $14.97.

First Guaranty Bancshares’s Moving Average

First Guaranty Bancshares’s worth is higher than its 50-day moving average of $20.70 and way higher than its 200-day moving average of $18.73.

6. GoPro (GPRO)

13.4% sales growth and 29.44% return on equity

GoPro, Inc. develops and sells cameras, drones, and mountable and wearable accessories in the United States and internationally.

GoPro’s sales growth this year is expected to be 28.7% and 7.8% for next year.

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 1.09B for the twelve trailing months.

Volume

Today’s last reported volume for GoPro is 2043990 which is 25.32% below its average volume of 2737200.

GoPro’s sales growth for the next quarter is 13.4%. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.44%.

Volatility

GoPro’s last day, last week, and last month’s current intraday variation average was 0.83%, 1.68%, and 2.45%, respectively.

GoPro’s highest amplitude of average volatility was 3.76% (day), 4.54% (last week), and 4.41% (last month), respectively.

GoPro’s Stock Yearly Top and Bottom Value

GoPro’s stock is valued at $8.54 at 19:22 EST, way under its 52-week high of $13.79 and way higher than its 52-week low of $7.02.

GoPro’s Moving Average

GoPro’s worth is way under its 50-day moving average of $9.75 and way under its 200-day moving average of $10.53.

7. Diodes Incorporated (DIOD)

9.5% sales growth and 20.38% return on equity

Diodes Incorporated designs, manufactures, and supplies application-specific standard products in the discrete, logic, and analog and mixed-signal semiconductor markets worldwide.

Diodes Incorporated’s sales growth this year is anticipated to be 7.9% and 2.8% for next year.

Year-on-year quarterly revenue growth grew by 37%, now sitting on 1.81B for the twelve trailing months.

Volume

Today’s last reported volume for Diodes Incorporated is 343480 which is 27.87% above its average volume of 268603.

Diodes Incorporated’s sales growth for the next quarter is 9.5%. The company’s growth estimates for the current quarter and the next is 36.6% and 17.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.38%.

Volatility

Diodes Incorporated’s last day, last week, and last month’s current intraday variation average was 4.09%, 2.59%, and 2.76%, respectively.

Diodes Incorporated’s highest amplitude of average volatility was 7.00% (day), 5.20% (last week), and 5.18% (last month), respectively.

Diodes Incorporated’s Stock Yearly Top and Bottom Value

Diodes Incorporated’s stock is valued at $93.00 at 19:22 EST, way under its 52-week high of $113.98 and way above its 52-week low of $68.01.

Diodes Incorporated’s Moving Average

Diodes Incorporated’s worth is below its 50-day moving average of $100.31 and higher than its 200-day moving average of $90.11.

8. Teleflex (TFX)

8.4% sales growth and 10.71% return on equity

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

Teleflex’s sales growth this year is anticipated to be 11.2% and 6.4% for next year.

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 2.69B for the twelve trailing months.

Volume

Today’s last reported volume for Teleflex is 403069 which is 12.81% above its average volume of 357285.

Teleflex’s sales growth for the next quarter is 8.4%. The company’s growth estimates for the current quarter and the next is 9.7% and 14.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.71%.

Volatility

Teleflex’s last day, last week, and last month’s current intraday variation average was 4.87%, 2.40%, and 1.93%, respectively.

Teleflex’s highest amplitude of average volatility was 7.70% (day), 4.63% (last week), and 3.05% (last month), respectively.

Teleflex’s Stock Yearly Top and Bottom Value

Teleflex’s stock is valued at $343.01 at 19:22 EST, way below its 52-week high of $449.38 and above its 52-week low of $328.39.

Teleflex’s Moving Average

Teleflex’s worth is below its 50-day moving average of $367.30 and way under its 200-day moving average of $388.60.

LEAVE A REPLY

Please enter your comment!
Please enter your name here